Trials / Withdrawn
WithdrawnNCT01784627
Trial of Computerized SBI to Reduce Teen Alcohol Use
Randomized Controlled Trial of Computerized SBI to Reduce Teen Alcohol Use
- Status
- Withdrawn
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Boston Children's Hospital · Academic / Other
- Sex
- All
- Age
- 9 Years – 20 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this project is to test the effectiveness of a computer-facilitated alcohol screening and brief intervention (c-ASBI) system for 12- to 18-year-old primary care patients in a multi-site, randomized comparative effectiveness trial. The investigators hypothesize that, among 12- to 18-year olds patients coming for annual well-care, those receiving c-ASBI will have lower rates of any alcohol use at 3-, 6-, and 12-month follow-ups compared to Treatment As Usual (TAU).
Detailed description
The Specific Aims are to 1) Test the effects of c-ASBI on any alcohol use; 2) Test the effects of c-ASBI separately as a prevention, therapeutic, and risk-reduction intervention; 3) Test the effects of c-ASBI separately on cannabis and tobacco use; explore its effects on other drug use; and 4) Assess potential moderators (e.g., age, gender, race/ethnicity, substance use history +/-, parent/sibling/peer substance use), mediators (e.g., Youth to Provider Connectedness,20 perceived harmfulness of alcohol and drug use), and explore c-ASBI's mechanism of action.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | c-ASBI | Participants in the c-ASBI group will complete a computerized screen for alcohol, cannabis, tobacco and other drugs, then view their screen score and 10 pages of information about the health effects of substance use and true-life stories on the computer. Their provider will see a report of their screen results and provide advice to stop or decrease their use, or, for those at high risk, referral to complete a computerized motivational enhancement therapy intervention. |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2017-10-01
- Completion
- 2017-10-01
- First posted
- 2013-02-06
- Last updated
- 2016-10-07
Locations
6 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01784627. Inclusion in this directory is not an endorsement.